Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials

Advances in the understanding of cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer treatment. Recent large-scale phase III tri...
Source: Clinical and Translational Medicine - Category: Internal Medicine Authors: Tags: Review Source Type: research